SCHEDULE: Intracoastal Capital Discloses 9.99% Stake in Applied DNA

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 9.99% beneficial ownership stake in Applied DNA Sciences, Inc. through a Schedule 13G filing.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") have filed a Schedule 13G regarding their beneficial ownership in Applied DNA Sciences, Inc.
• The Reporting Persons collectively hold beneficial ownership of 143,336 shares of Common Stock, par value $0.001 per share.
• This ownership represents approximately 9.99% of the outstanding Common Stock of Applied DNA Sciences, Inc.
• The beneficial ownership is primarily derived from shares issuable upon the exercise of Intracoastal Warrant 1.
• The warrants include blocker provisions that prevent the holder from exercising them to the extent that such exercise would result in beneficial ownership exceeding 9.99% (for Warrant 1) or 4.99% (for Warrant 2).
• Without these blocker provisions, the Reporting Persons would have beneficial ownership of 435,767 shares of Common Stock.
• The securities were acquired and are held for investment purposes and not with the intent to change or influence control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing is a factual disclosure of a passive ownership stake by an institutional investor, which can be seen as a vote of confidence, but it does not contain new performance data or strategic updates.

Positives

• The disclosure of a significant passive stake by an institutional investor group (Intracoastal Capital LLC, Mitchell P. Kopin, and Daniel B. Asher) could be interpreted as a vote of confidence in Applied DNA Sciences, Inc.

Future Outlook

No forward-looking statements or guidance regarding the company's performance or strategic direction are provided by the reporting persons in this filing.

Industry Context

This filing represents a standard disclosure of a passive, significant ownership stake by an institutional investor in a publicly traded company. Such disclosures are common and provide transparency regarding major shareholders, which can be of interest to the market, particularly in the biotechnology or specialized technology sectors where investor confidence is key.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, which may be viewed as a positive signal of investor interest in the company.

Key Dates

Recommendation

This Schedule 13G filing indicates a passive, significant ownership stake by Intracoastal Capital LLC and its principals in Applied DNA Sciences, Inc. While the presence of an institutional investor can be a positive signal, the filing explicitly states the stake is not for influencing control. It does not provide new financial performance data or strategic updates that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate for existing investors, as the filing does not present new information to alter current positions.

Keywords

Applied DNA Sciences, Intracoastal Capital, Mitchell P. Kopin, Daniel B. Asher, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Institutional Investor, Equity Stake